Newsfeeds Archive - Page 34 of 167

1 minute read

General

Microsoft And Viasat Announce Collaboration Through Microsoft Airband Initiative

December 14, 9:07 AM

REDMOND, Wash., Dec. 14, 2022 /PRNewswire/ -- On Wednesday, Microsoft Corp. (NASDAQ:MSFT) and Viasat (NASDAQ:VSAT) announced a new partnership to help deliver internet access to 10 million people

MSFT

1 minute read

Urica Therapeutics Expands Exclusive License Agreement With Fuji Yakuhin Co. Ltd. To Develop Dotinurad In Additional Territories Including Turkey, Middle East And North Africa

By Bill Haddad

December 14, 9:01 AM

Urica Therapeutics, Inc. ("Urica" or the "Company") (formerly known as UR-1 Therapeutics, Inc.), a Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress") subsidiary company focused on the

FBIO

1 minute read

Kymera Announces Results From Phase 1 Clinical Trial Evaluating KT-474 In Patients With HS And AD And Sanofi’s Decision To Advance KT-474 Into Phase 2 Clinical Trials

By Bill Haddad

December 14, 8:12 AM

KT-474 Phase 1 clinical data in HS and AD patients demonstrate robust IRAK4 knockdown in blood and active skin lesions and systemic suppression of proinflammatory cytokines and chemokines with a favorable safety

KYMR

1 minute read

Avidity Announces AOC 1001 Phase 1/2 MARINA Data Demonstrating Successful Targeted Delivery Of RNA to Muscle

By Bill Haddad

December 14, 8:08 AM

AOC 1001 delivered siRNA to skeletal muscle and produced meaningful DMPK reduction in 100% of participants with a 45% mean reduction in DMPK after a single dose of 1 mg/kg or two doses of 2 mg/kg AOC

RNA

1 minute read

Germany Calls For Global Regulation Of Crypto Industry

By Bill Haddad

December 14, 7:29 AM

-Bloomberg

BTC

1 minute read

Icosavax Provides Six-Month Update From Phase 1/1b Trial Of IVX-121

By Bill Haddad

December 13, 5:09 PM

- In new data from Phase 1/1b study, IVX-121 showed sustained immunologic response at six months; geometric mean titers (GMT) against RSV-A through day 180 persisting at 64-98% of the GMTs at day 28 in older

ICVX

1 minute read

Pfizer Says Actively Collaborating With All Stakeholders To Secure An Adequate Supply Of Covid Drug Paxlovid In China

By Bill Haddad

December 13, 2:03 PM

-Reuters

PFE

1 minute read

Midatech Pharma: Deal To Be Satisfied By Issue Of 75.9M New Shares Of 0.1P Each In Co Capital At Exchange Ratio Of 0.9556 Shares For Each Bioasis Share

By Bill Haddad

December 13, 11:26 AM

-Reuters

MTP

1 minute read

Russian Deputy Foreign Minister: Russia And US To Continue Talks On Points Of Contention In New Year

By Bill Haddad

December 13, 11:21 AM

-Russian State Media

RSX

1 minute read

Rafael Holdings Q1 EPS $(0.22) Up From $(0.75) YoY

By Bill Haddad

December 13, 8:07 AM

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.22) per share. This is a 70.67 percent increase over losses of $(0.75) per share from the same period last year.

RFL